Ebselen as an add-on Treatment in Hypo/Mania

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Bipolar DisorderBipolar Disorder, Manic
Interventions
DRUG

Ebselen

Ebselen is an opaque capsule containing 200 mg of ebselen is a selenium-based GPx mimic and IMPase inhibitor.

DRUG

Placebo oral capsule

Placebo is identical in appearance to the ebselen capsules

Trial Locations (1)

OX37JX

Neurosciences Building, Dept. Psychiatry, Warneford Hospital, Oxford

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

collaborator

Sound Pharmaceuticals, Incorporated

INDUSTRY

lead

University of Oxford

OTHER

NCT03013400 - Ebselen as an add-on Treatment in Hypo/Mania | Biotech Hunter | Biotech Hunter